世界のシングルユースバイオリアクター(SUB)市場(~2028年):製品別(装置、メディアバッグ、ろ過アセンブリ)、種類別(攪拌槽、バブルカラム)、細胞タイプ別(哺乳類、バクテリア、酵母)、分子別(mAbs、ワクチン)、エンドユーザー別(製薬、バイオテクノロジー、CRO、CMO)、地域別

【英語タイトル】Single Use Bioreactors Market by Product (System, Media Bag, Filtration assemblies), Type (Stirred tank, Bubble column), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines), End User (Pharma, Biotech, CROs, CMOs) & Region - Global Forecast to 2028

MarketsandMarketsが出版した調査資料(BT2863-23)・商品コード:BT2863-23
・発行会社(調査会社):MarketsandMarkets
・発行日:2023年3月24日
・ページ数:349
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

MarketsandMarkets社発行の当レポートによると、世界のシングルユースバイオリアクター(SUB)市場規模が2023年41億ドルから2028年100億ドルまで、予測期間中(2023年~2028年)年平均19.0%成長すると予測されています。当レポートは、シングルユースバイオリアクター(SUB)の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(シングルユースバイオリアクター装置、シングルユースバイオリアクターメディアバッグ、シングルユースバイオリアクターろ過アセンブリ、その他)分析、種類別(攪拌槽シングルユースバイオリアクター、波動誘導シングルユースバイオリアクター、気泡塔シングルユースバイオリアクター、その他)分析、分子別(モノクローナル抗体、ワクチン、幹細胞、遺伝子改変細胞、その他)分析、細胞タイプ別(哺乳類細胞、バクテリア細胞、酵母細胞、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Sartorius AG (Germany)、Thermo Fisher Scientific (US)、Danaher Corporation (US)、and Merck Millipore (Germany)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要

・世界のシングルユースバイオリアクター(SUB)市場規模:製品別
- シングルユースバイオリアクター装置の市場規模
- シングルユースバイオリアクターメディアバッグの市場規模
- シングルユースバイオリアクターろ過アセンブリの市場規模
- その他製品の市場規模

・世界のシングルユースバイオリアクター(SUB)市場規模:種類別
- 攪拌槽シングルユースバイオリアクターの市場規模
- 波動誘導シングルユースバイオリアクターの市場規模
- 気泡塔シングルユースバイオリアクターの市場規模
- その他種類の市場規模

・世界のシングルユースバイオリアクター(SUB)市場規模:分子別
- モノクローナル抗体の市場規模
- ワクチンの市場規模
- 幹細胞の市場規模
- 遺伝子改変細胞の市場規模
- その他分子の市場規模

・世界のシングルユースバイオリアクター(SUB)市場規模:細胞タイプ別
- 哺乳類細胞の市場規模
- バクテリア細胞の市場規模
- 酵母細胞の市場規模
- その他細胞タイプの市場規模

・世界のシングルユースバイオリアクター(SUB)市場規模:地域別
- 北米のシングルユースバイオリアクター(SUB)市場規模
- ヨーロッパのシングルユースバイオリアクター(SUB)市場規模
- アジア太平洋のシングルユースバイオリアクター(SUB)市場規模
- 中南米のシングルユースバイオリアクター(SUB)市場規模
- 中東/アフリカのシングルユースバイオリアクター(SUB)市場規模

・競争状況
・企業情報

“世界のシングルユースバイオリアクター(SUB)市場は、2023年の42億米ドルから2028年には100億米ドルに達し、2023年から2028年の予測期間中のCAGRは19.0%と予想”
従来のバイオリアクターと比較してシングルユースバイオリアクター(SUB)の操作の複雑性が低いこと、新興企業や中小企業の間でシングルユースバイオリアクター(SUB)の採用が増加していること、水やエネルギーの消費量が少ないことなどが、同市場に成長をもたらすと予想されています。

“バイオ生産がアプリケーションセグメントで最大シェアを占める見込み”
シングルユースバイオリアクター(SUB)市場は、用途に基づき、研究開発、プロセス開発、バイオ生産に区分されます。バイオプロダクションセグメントは、バイオ製造プロセスにおけるシングルユースバイオリアクター(SUB)の使用の増加や、柔軟性や拡張性などの利点からCMOにおけるシングルユースバイオリアクター(SUB)製品の需要の増加により、2022年の市場で最大のシェアを占めています。

“シングルユースバイオリアクター(SUB)市場のエンドユーザーセグメントで最も大きなシェアを占めたのは製薬・バイオテクノロジー企業セグメント”
エンドユーザーに基づき、シングルユースバイオリアクター(SUB)市場は製薬&バイオテクノロジー企業、CRO&CMO、学術&研究機関に区分されます。2022年には、製薬会社、バイオ医薬品会社、バイオテクノロジー会社による研究開発イニシアチブの増加、生物製剤およびバイオシミラー生産の増加により、製薬会社およびバイオテクノロジー会社セグメントがシングルユースバイオリアクター(SUB)市場で最大のシェアを占めています。

“欧州はシングルユースバイオリアクター(SUB)市場で2番目に大きい地域”
シングルユースバイオリアクター(SUB)市場は、北米、欧州、アジア太平洋、中南米(LATAM)、中東・アフリカ(MEA)に区分されます。北米に次いで、欧州は世界第2位の医薬品地域市場です。同地域のCDMOやバイオファーマ企業によるシングルユースバイオリアクター(SUB)の採用が増加し、資金提供や投資による政府の支援が市場の成長を支えています。

本レポートのために実施した一次インタビューは以下のように分類されます:
- 回答者別 供給側70%、需要側30%
- 役職別 管理職:45%、CXOおよびディレクタークラス:30%、経営幹部:25%
- 地域別 北米20%、欧州10%、アジア太平洋55%、中南米10%、中東・アフリカ5%

シングルユースバイオリアクター(SUB)市場の主要プレイヤーは、Sartorius AG (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany)です。

調査範囲
この調査レポートは、シングルユースバイオリアクター(SUB)市場の詳細を掲載しています。製品、タイプ、細胞の種類、分子の種類、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの企業プロフィールや最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、シングルユースバイオリアクター(SUB)市場全体とそのサブセグメントにおける収益概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置付け、適切な市場参入戦略を立てるのにも役立ちます。本レポートは、関係者が市場動向を理解し、主要な市場促進要因、阻害要因、課題、動向、機会に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します:
- シングルユースバイオリアクター(SUB)市場の成長に影響を与える主要推進要因の分析(新興企業や中小企業におけるシングルユースバイオリアクター(SUB)の採用の増加、従来のバイオリアクターと比較したシングルユースバイオリアクター(SUB)の操作の複雑性の軽減、エネルギーと水の消費量の低減、生物製剤およびバイオシミラー市場の成長、シングルユースバイオリアクター(SUB)ーの技術的進歩)、 阻害要因(シングルユースバイオリアクター(SUB)に関する規制上の懸念、溶出物・抽出物に関する問題)、機会(持続可能な製造のためのハイブリッド施設、新興市場)、課題(シングルユース設計の標準化、廃棄物の処理)分析。
- 製品開発/イノベーション: 新しく発売される製品に関する詳細な洞察と、シングルユースバイオリアクター(SUB)市場の技術評価。
- 市場開発: 有利な市場に関する包括的な情報 – 当レポートでは、さまざまな地域のシングルユースバイオリアクター(SUB)市場を分析。
- 市場の多様化: シングルユースバイオリアクター(SUB)市場における新製品、未開拓の産地、最近の開発、投資に関する詳細な情報。
- 競合他社の評価: シングルユースバイオリアクター(SUB)市場におけるSartorius AG (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany)などの主要企業の市場シェア、成長戦略、製品ラインアップを詳細に評価。また、シングルユースバイオリアクター(SUB)市場の動向を理解し、市場動向とともに主要な市場促進要因、阻害要因、課題、機会に関する情報を提供。

❖ レポートの目次 ❖

1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 48
1.2.1 INCLUSIONS AND EXCLUSIONS 49
1.3 MARKET SCOPE 50
FIGURE 1 SINGLE-USE BIOREACTORS MARKET SEGMENTATION 50
1.3.1 YEARS CONSIDERED 50
1.4 CURRENCY 51
1.5 LIMITATIONS 51
1.6 STAKEHOLDERS 51
1.7 SUMMARY OF CHANGES 52
1.7.1 RECESSION IMPACT 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
FIGURE 2 RESEARCH DESIGN 54
2.1.1 SECONDARY DATA 55
2.1.2 PRIMARY DATA 56
FIGURE 3 SINGLE-USE BIOREACTORS MARKET: BREAKDOWN OF PRIMARIES 56
2.2 MARKET SIZE ESTIMATION 57
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 57
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 58
FIGURE 6 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE SHARE ANALYSIS (2022) 58
2.2.1 INSIGHTS FROM PRIMARIES 59
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 59
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 60
2.3 GROWTH FORECAST 61
FIGURE 9 SINGLE-USE BIOREACTORS MARKET: CAGR PROJECTIONS 61
FIGURE 10 SINGLE-USE BIOREACTORS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 62
FIGURE 11 DATA TRIANGULATION METHODOLOGY 63
2.5 RESEARCH ASSUMPTIONS 63
2.6 RISK ANALYSIS 64
2.7 RECESSION IMPACT ON SINGLE-USE BIOREACTORS MARKET 64
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 64

3 EXECUTIVE SUMMARY 66
FIGURE 12 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 66
FIGURE 13 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 67
FIGURE 14 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2023 VS. 2028 (USD MILLION) 68
FIGURE 15 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2023 VS. 2028 (USD MILLION) 68
FIGURE 16 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 69
FIGURE 17 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 70
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF SINGLE-USE BIOREACTORS MARKET 71
4 PREMIUM INSIGHTS 72
4.1 SINGLE-USE BIOREACTORS MARKET OVERVIEW 72
FIGURE 19 GROWING BIOPHARMACEUTICAL INDUSTRY TO DRIVE MARKET 72
4.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SHARE, BY TYPE OF MOLECULE AND COUNTRY (2022) 73
FIGURE 20 MONOCLONAL ANTIBODIES SEGMENT DOMINATED NORTH AMERICAN SINGLE-USE BIOREACTORS MARKET IN 2022 73
4.3 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 74
FIGURE 21 SINGLE-USE BIOREACTOR SYSTEMS TO CONTINUE TO DOMINATE MARKET IN 2028 74
4.4 SINGLE-USE BIOREACTORS MARKET SHARE, BY END USER (2022) 74
FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 74
4.5 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 75
FIGURE 23 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE IN SINGLE-USE BIOREACTORS MARKET FROM 2023 TO 2028 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 76
FIGURE 24 SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76
TABLE 2 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS 77
5.2.1 DRIVERS 77
5.2.1.1 Increasing adoption of single-use bioreactors among startups and SMEs 77
5.2.1.2 Reduced operational complexity of single-use bioreactors compared to conventional bioreactors 78
5.2.1.3 Lower energy and water consumption 78
5.2.1.4 Growing biologics and biosimilars market 78
5.2.1.5 Technological advancements in single-use bioreactors 79
5.2.2 RESTRAINTS 79
5.2.2.1 Regulatory concerns related to single-use bioreactors 79
5.2.2.2 Issues related to leachables and extractables 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Hybrid facilities for sustainable manufacturing 81
5.2.3.2 Emerging markets 81
5.2.4 CHALLENGES 82
5.2.4.1 Standardization of single-use designs 82
5.2.4.2 Disposal of waste 82
5.3 INDUSTRY TRENDS 82
5.3.1 INCREASING FOCUS ON SINGLE-USE BIOPROCESSING CAPACITIES AND TECHNOLOGICAL COMPETITIVENESS 82
TABLE 3 SINGLE-USE BIOREACTOR CAPACITY EXPANSIONS BY MAJOR PLAYERS 83
5.3.2 INCREASING ADOPTION OF SINGLE-USE SYSTEMS BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS 83
5.3.3 AUTOMATION IN SINGLE-USE BIOREACTORS 84
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 84
FIGURE 25 REVENUE SHIFT AND NEW POCKETS FOR SINGLE-USE BIOREACTOR PROVIDERS 85
5.5 PRICING ANALYSIS 85
5.6 VALUE CHAIN ANALYSIS 86
FIGURE 26 VALUE CHAIN ANALYSIS OF SINGLE-USE BIOREACTORS: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE 86
5.7 SUPPLY CHAIN ANALYSIS 88
FIGURE 27 SINGLE-USE BIOREACTORS MARKET: SUPPLY CHAIN ANALYSIS 88
TABLE 4 OVERALL SUPPLY CHAIN ECOSYSTEM FOR SINGLE-USE BIOREACTORS 89
5.8 ECOSYSTEM ANALYSIS 90
FIGURE 28 SINGLE-USE BIOREACTORS MARKET: ECOSYSTEM ANALYSIS 90
5.9 TECHNOLOGY ANALYSIS 91
5.9.1 WAVE-INDUCED MOTION TECHNOLOGY 91
5.9.2 BUBBLE-COLUMN TECHNOLOGY 91
5.9.3 STIRRED-TANK TECHNOLOGY 92
5.9.4 VERTICALLY PERFORATED DISCS 92
5.10 PATENT ANALYSIS 92
FIGURE 29 PATENT APPLICATIONS FOR SINGLE-USE BIOREACTORS MARKET, JANUARY 2012–FEBRUARY 2023 92
TABLE 5 INDICATIVE LIST OF PATENTS IN SINGLE-USE BIOREACTORS MARKET 93
5.11 KEY CONFERENCES AND EVENTS DURING 2023–2024 94
TABLE 6 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 94
5.12 REGULATORY ANALYSIS 95
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
5.13 PORTER’S FIVE FORCES ANALYSIS 97
TABLE 11 SINGLE-USE BIOREACTORS MARKET: PORTER’S FIVE FORCES ANALYSIS 97
5.13.1 THREAT OF NEW ENTRANTS 97
5.13.2 THREAT OF SUBSTITUTES 98
5.13.3 BARGAINING POWER OF SUPPLIERS 98
5.13.4 BARGAINING POWER OF BUYERS 98
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 98
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 99
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTOR PRODUCTS 99
5.14.2 BUYING CRITERIA FOR SINGLE-USE BIOREACTORS 99
FIGURE 31 KEY BUYING CRITERIA FOR END USERS 99
6 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT 100
6.1 INTRODUCTION 101
TABLE 12 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 101
6.2 SINGLE-USE BIOREACTOR SYSTEMS 101
6.2.1 ADVANTAGES OFFERED OVER CONVENTIONAL BIOREACTORS TO DRIVE ADOPTION 101
TABLE 13 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS OFFERED BY MARKET PLAYERS 102
TABLE 14 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 102
TABLE 15 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 16 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 17 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 18 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 19 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.2.2 UP TO 10 L 104
TABLE 20 UP TO 10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 21 NORTH AMERICA: UP TO 10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 22 EUROPE: UP TO 10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 23 ASIA PACIFIC: UP TO 10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 24 LATIN AMERICA: UP TO 10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.2.3 11–100 L 107
TABLE 25 11 TO 100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 26 NORTH AMERICA: 11 TO 100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 27 EUROPE: 11 TO 100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 28 ASIA PACIFIC: 11 TO 100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 29 LATIN AMERICA: 11 TO 100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
6.2.4 101–500 L 109
TABLE 30 101 TO 500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 31 NORTH AMERICA: 101 TO 500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 32 EUROPE: 101 TO 500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 33 ASIA PACIFIC: 101 TO 500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 34 LATIN AMERICA: 101 TO 500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.2.5 501–1,500 L 112
TABLE 35 501 TO 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 36 NORTH AMERICA: 501 TO 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 37 EUROPE: 501 TO 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 38 ASIA PACIFIC: 501 TO 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 39 LATIN AMERICA: 501 TO 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
6.2.6 ABOVE 1,500 L 114
TABLE 40 ABOVE 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 41 NORTH AMERICA: ABOVE 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 42 EUROPE: ABOVE 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 43 ASIA PACIFIC: ABOVE 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 44 LATIN AMERICA: ABOVE 1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
6.3 SINGLE-USE MEDIA BAGS 117
6.3.1 MAINLY USED IN BUFFER AND MEDIA STORAGE 117
TABLE 45 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 46 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 47 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 48 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 49 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 50 LATIN AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.3.2 2D BAGS 120
TABLE 51 2D BAGS MARKET, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 52 NORTH AMERICA: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 53 EUROPE: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 54 ASIA PACIFIC: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 55 LATIN AMERICA: 2D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.3.3 3D BAGS 122
TABLE 56 3D BAGS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 57 NORTH AMERICA: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 58 EUROPE: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 59 ASIA PACIFIC: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 60 LATIN AMERICA: 3D BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.3.4 OTHER BAGS 124
TABLE 61 OTHER BAGS MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 62 NORTH AMERICA: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 63 EUROPE: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 64 ASIA PACIFIC: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 65 LATIN AMERICA: OTHER BAGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.4 SINGLE-USE FILTRATION ASSEMBLIES 126
6.4.1 REDUCED RISK OF CONTAMINATION TO PROPEL DEMAND FOR SINGLE-USE FILTRATION ASSEMBLIES 126
TABLE 66 SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 67 NORTH AMERICA: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 68 EUROPE: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 69 ASIA PACIFIC: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 70 LATIN AMERICA: SINGLE-USE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.5 OTHER PRODUCTS 128
TABLE 71 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 72 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 73 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 74 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 75 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
7 SINGLE-USE BIOREACTORS MARKET, BY TYPE 131
7.1 INTRODUCTION 132
TABLE 76 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
7.2 STIRRED-TANK SINGLE-USE BIOREACTORS 132
7.2.1 PREFERRED FOR AEROBIC MICROBIAL CELL CULTURES 132
TABLE 77 EXAMPLES OF STIRRED-TANK SINGLE-USE BIOREACTORS OFFERED BY MARKET PLAYERS 133
TABLE 78 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 133
TABLE 79 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 80 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 81 ASIA PACIFIC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 82 LATIN AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
7.3 WAVE-INDUCED SINGLE-USE BIOREACTORS 135
7.3.1 BEST SUITED FOR SHEAR STRESS-SENSITIVE CELL LINES 135
TABLE 83 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 84 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 85 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 86 ASIA PACIFIC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 87 LATIN AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
7.4 BUBBLE-COLUMN SINGLE-USE BIOREACTORS 138
7.4.1 EFFICIENT MASS AND HEAT TRANSFER CAPABILITY TO DRIVE GROWTH 138
TABLE 88 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 89 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 90 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 91 ASIA PACIFIC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 92 LATIN AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
7.5 OTHER SINGLE-USE BIOREACTORS 141
TABLE 93 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 94 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 95 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 96 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 97 LATIN AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
8 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE 144
8.1 INTRODUCTION 145
TABLE 98 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 145
8.2 MONOCLONAL ANTIBODIES 145
8.2.1 GROWING THERAPEUTIC APPLICATIONS TO DRIVE DEMAND FOR SINGLE-USE BIOREACTORS IN R&D AND MANUFACTURING APPLICATIONS 145
TABLE 99 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 100 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 101 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 102 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 103 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2021–2028 (USD MILLION) 148
8.3 VACCINES 148
8.3.1 USE OF SINGLE-USE SYSTEMS FOR VACCINE PRODUCTION TO INCREASE PRODUCTION CAPACITIES WITH REDUCED COST 148
TABLE 104 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 105 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 106 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 107 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 108 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2021–2028 (USD MILLION) 151
8.4 STEM CELLS 151
8.4.1 GROWING RESEARCH AND COMMERCIALIZATION OF STEM CELL THERAPIES TO DRIVE MARKET 151
TABLE 109 SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION) 152
TABLE 110 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 111 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 112 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 113 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 154
8.5 GENE-MODIFIED CELLS 154
8.5.1 GROWING MARKET FOR GENE AND CELL THERAPIES TO DRIVE MARKET 154
TABLE 114 SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 115 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 116 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 117 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 118 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR GENE-MODIFIED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 157
8.6 OTHER MOLECULES 157
TABLE 119 SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY REGION, 2021–2028 (USD MILLION) 157
TABLE 120 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 121 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 122 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 123 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2021–2028 (USD MILLION) 159

9 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL 160
9.1 INTRODUCTION 161
TABLE 124 SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 161
9.2 MAMMALIAN CELLS 161
9.2.1 USED IN PRODUCTION OF MONOCLONAL ANTIBODIES AND THERAPEUTIC PROTEINS 161
TABLE 125 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2021–2028 (USD MILLION) 162
TABLE 126 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 127 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 128 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 129 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 164
9.3 BACTERIAL CELLS 164
9.3.1 GROWING ADOPTION IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION TO DRIVE MARKET 164
TABLE 130 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2021–2028 (USD MILLION) 164
TABLE 131 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 132 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 133 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 134 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 166
9.4 YEAST CELLS 166
9.4.1 FASTER GROWTH RATE AND MINIMAL MEDIA CONDITIONS TO DRIVE ADOPTION IN RECOMBINANT PROTEIN PRODUCTION 166
TABLE 135 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION, 2021–2028 (USD MILLION) 167
TABLE 136 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 137 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 138 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 139 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 168
9.5 OTHER CELLS 169
TABLE 140 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2021–2028 (USD MILLION) 169
TABLE 141 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 142 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 143 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 144 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 170
10 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION 171
10.1 INTRODUCTION 172
TABLE 145 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172
10.2 BIOPRODUCTION 172
10.2.1 INCREASING BIOPHARMACEUTICAL PRODUCTION TO DRIVE DEMAND FOR COST-EFFECTIVE SINGLE-USE BIOREACTORS 172
TABLE 146 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2021–2028 (USD MILLION) 173
TABLE 147 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 148 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 149 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 150 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 175
10.3 PROCESS DEVELOPMENT 175
10.3.1 LOW CROSS-CONTAMINATION RISK AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET 175
TABLE 151 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 175
TABLE 152 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 153 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 154 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 155 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 177
10.4 RESEARCH AND DEVELOPMENT 177
10.4.1 SINGLE-USE BIOREACTORS INCREASINGLY ADOPTED FOR R&D APPLICATIONS DUE TO COST-EFFECTIVENESS 177
TABLE 156 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 178
TABLE 157 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 158 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 159 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 160 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 180
11 SINGLE-USE BIOREACTORS MARKET, BY END USER 181
11.1 INTRODUCTION 182
TABLE 161 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 182
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 182
11.2.1 GROWING BIOLOGICS AND BIOSIMILARS MARKET TO INCREASE DEMAND FOR SINGLE-USE BIOREACTORS 182
TABLE 162 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 163 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 164 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 165 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 166 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 185
11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 185
11.3.1 INCREASING OUTSOURCING OF R&D AND MANUFACTURING SERVICES BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SUPPORT MARKET GROWTH 185
TABLE 167 SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY REGION, 2021–2028 (USD MILLION) 186
TABLE 168 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 169 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 170 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 171 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CMOS, BY COUNTRY, 2021–2028 (USD MILLION) 187
11.4 ACADEMIC & RESEARCH INSTITUTES 188
11.4.1 GROWING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET 188
TABLE 172 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 188
TABLE 173 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 174 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 175 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 176 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 190
12 SINGLE-USE BIOREACTORS MARKET, BY REGION 191
12.1 INTRODUCTION 192
TABLE 177 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 192
12.2 NORTH AMERICA 192
FIGURE 32 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT 193
TABLE 178 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 179 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 194
TABLE 180 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 194
TABLE 181 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 182 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 183 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 196
TABLE 184 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 196
TABLE 185 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 186 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 197
12.2.1 US 197
12.2.1.1 US to dominate single-use bioreactors market in North America 197
TABLE 187 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 198
TABLE 188 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 198
TABLE 189 US: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 190 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 191 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 200
TABLE 192 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 200
TABLE 193 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200
TABLE 194 US: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 201
12.2.2 CANADA 201
12.2.2.1 Increasing focus of biopharmaceutical companies on enhancing manufacturing capacity to support market growth 201
TABLE 195 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 201
TABLE 196 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 202
TABLE 197 CANADA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 198 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 199 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 203
TABLE 200 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 203
TABLE 201 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 203
TABLE 202 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 204
12.2.3 NORTH AMERICA: RECESSION IMPACT 204
12.3 EUROPE 205
TABLE 203 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 204 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 205
TABLE 205 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 206
TABLE 206 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 207 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 207
TABLE 209 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 207
TABLE 210 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 207
TABLE 211 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 208
12.3.1 GERMANY 208
12.3.1.1 Increasing adoption of single-use bioreactors by CDM0s and biopharma companies to propel market 208
TABLE 212 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 209
TABLE 213 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 209
TABLE 214 GERMANY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 215 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 216 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 211
TABLE 217 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 211
TABLE 218 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 219 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 212
12.3.2 UK 212
12.3.2.1 Government support to biotech companies to result in high adoption of single-use bioreactors 212
TABLE 220 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213
TABLE 221 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 213
TABLE 222 UK: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 223 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 224 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 215
TABLE 225 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 215
TABLE 226 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 227 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 216

12.3.3 FRANCE 216
12.3.3.1 Growing investments by life sciences companies in research infrastructure projects to contribute to market growth 216
TABLE 228 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 217
TABLE 229 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 217
TABLE 230 FRANCE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 231 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 232 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 218
TABLE 233 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 219
TABLE 234 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 235 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 219
12.3.4 ITALY 220
12.3.4.1 Increasing investments in drug discovery and single-use system development to boost market 220
TABLE 236 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 220
TABLE 237 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 221
TABLE 238 ITALY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 239 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 240 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 222
TABLE 241 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 223
TABLE 242 ITALY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 223
TABLE 243 ITALY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 223
12.3.5 SPAIN 224
12.3.5.1 Rising use of single-use bioprocessing technologies to foster market growth 224
TABLE 244 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 224
TABLE 245 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 224
TABLE 246 SPAIN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 247 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 248 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 226
TABLE 249 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 226
TABLE 250 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 226
TABLE 251 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 227
12.3.6 REST OF EUROPE 227
TABLE 252 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 228
TABLE 253 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 228
TABLE 254 REST OF EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 255 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 256 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 230
TABLE 257 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 230
TABLE 258 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230
TABLE 259 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 231
12.3.7 EUROPE: RECESSION IMPACT 231
12.4 ASIA PACIFIC 232
FIGURE 33 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOTS 233
TABLE 260 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 234
TABLE 261 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 234
TABLE 262 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY RANGE SCALE, 2021–2028 (USD MILLION) 235
TABLE 263 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 264 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 265 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 236
TABLE 266 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 236
TABLE 267 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 237
TABLE 268 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 237
12.4.1 CHINA 237
12.4.1.1 Land leasing and subsidy initiatives of government for biopharma companies and CMOs to contribute to market growth 237
TABLE 269 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 238
TABLE 270 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 239
TABLE 271 CHINA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 272 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 273 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 240
TABLE 274 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 241
TABLE 275 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 241
TABLE 276 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 241
12.4.2 SOUTH KOREA 242
12.4.2.1 Increasing use of single-use solutions in R&D and commercial manufacturing to fuel market growth 242
TABLE 277 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 242
TABLE 278 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 243
TABLE 279 SOUTH KOREA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 280 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 281 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 244
TABLE 282 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 245
TABLE 283 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 245
TABLE 284 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 245
12.4.3 JAPAN 246
12.4.3.1 Growing geriatric population and rising use of regenerative medicines to stimulate market growth 246
TABLE 285 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 246
TABLE 286 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 247
TABLE 287 JAPAN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 288 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 289 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 248
TABLE 290 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 249
TABLE 291 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 249
TABLE 292 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 249
12.4.4 INDIA 250
12.4.4.1 Thriving pharma and biotech industries to create significant demand for single-use bioreactors 250
TABLE 293 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 250
TABLE 294 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 251
TABLE 295 INDIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 296 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 297 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 252
TABLE 298 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 253
TABLE 299 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 253
TABLE 300 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 253
12.4.5 REST OF ASIA PACIFIC 254
TABLE 301 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 254
TABLE 302 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 255
TABLE 303 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 304 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 305 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 256
TABLE 306 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 257
TABLE 307 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 257
TABLE 308 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 257
12.4.6 ASIA PACIFIC: RECESSION IMPACT 258
12.5 LATIN AMERICA 258
TABLE 309 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 258
TABLE 310 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 259
TABLE 311 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 259
TABLE 312 LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 313 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 314 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 261
TABLE 315 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 261
TABLE 316 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 261
TABLE 317 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 262
12.5.1 BRAZIL 262
12.5.1.1 Increasing investments in biomanufacturing to support market growth 262
TABLE 318 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 263
TABLE 319 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 263
TABLE 320 BRAZIL: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 321 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 322 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 265
TABLE 323 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 265
TABLE 324 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 265
TABLE 325 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 266
12.5.2 REST OF LATIN AMERICA 266
TABLE 326 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 267
TABLE 327 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 267
TABLE 328 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 329 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 330 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 269
TABLE 331 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 269
TABLE 332 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 270
TABLE 333 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 270
12.5.3 LATIN AMERICA: RECESSION IMPACT 270
12.6 MIDDLE EAST & AFRICA 271
12.6.1 STRATEGIC COLLABORATIONS AND AGREEMENTS IN BIOMANUFACTURING FIELD TO BOOST DEMAND FOR SINGLE-USE BIOREACTORS 271
TABLE 334 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 271
TABLE 335 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2021–2028 (USD MILLION) 272
TABLE 336 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 337 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 338 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF MOLECULE, 2021–2028 (USD MILLION) 273
TABLE 339 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL, 2021–2028 (USD MILLION) 274
TABLE 340 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 274
TABLE 341 MIDDLE EAST & AFRICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2021–2028 (USD MILLION) 274
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 275
13 COMPETITIVE LANDSCAPE 276
13.1 INTRODUCTION 276
13.2 STRATEGIES ADOPTED BY KEY PLAYERS 277
FIGURE 34 SINGLE-USE BIOREACTORS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 277
13.3 REVENUE SHARE ANALYSIS 278
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 278
13.4 MARKET SHARE ANALYSIS 278
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 279
TABLE 342 SINGLE-USE BIOREACTORS MARKET: DEGREE OF COMPETITION 279
13.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS 280
FIGURE 37 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 281
13.5.1 STARS 282
13.5.2 EMERGING LEADERS 282
13.5.3 PERVASIVE PLAYERS 282
13.5.4 PARTICIPANTS 282
13.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 283
13.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 283
TABLE 343 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET 283
13.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 284
TABLE 344 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET 284
13.7 COMPANY EVALUATION QUADRANT: STARTUPS/SMES 285
FIGURE 38 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022 285
13.7.1 PROGRESSIVE COMPANIES 286
13.7.2 STARTING BLOCKS 286
13.7.3 RESPONSIVE COMPANIES 286
13.7.4 DYNAMIC COMPANIES 286
13.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 287
TABLE 345 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 287
TABLE 346 SINGLE-USE BIOREACTORS MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS 288
13.9 COMPETITIVE SCENARIO AND TRENDS 289
13.9.1 PRODUCT LAUNCHES 289
TABLE 347 SINGLE-USE BIOREACTORS MARKET: PRODUCT LAUNCHES, JANUARY 2020–FEBRUARY 2023 289
13.9.2 DEALS 290
TABLE 348 SINGLE-USE BIOREACTORS MARKET: DEALS, JANUARY 2020–FEBRUARY 2023 290
13.9.3 OTHER DEVELOPMENTS 291
TABLE 349 SINGLE-USE BIOREACTORS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–FEBRUARY 2023 291
14 COMPANY PROFILES 295
14.1 KEY PLAYERS 295
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 SARTORIUS AG 295
TABLE 350 SARTORIUS AG: COMPANY OVERVIEW 295
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022) 296
TABLE 351 SARTORIUS AG: PRODUCT OFFERINGS 297
TABLE 352 SARTORIUS AG: PRODUCT LAUNCHES 297
TABLE 353 SARTORIUS AG: DEALS 298
TABLE 354 SARTORIUS AG: OTHER DEVELOPMENTS 298
14.1.2 DANAHER CORPORATION 300
TABLE 355 DANAHER CORPORATION: COMPANY OVERVIEW 300
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 301
TABLE 356 DANAHER CORPORATION: PRODUCT OFFERINGS 302
TABLE 357 DANAHER CORPORATION: DEALS 304
TABLE 358 DANAHER CORPORATION: OTHER DEVELOPMENTS 305
14.1.3 THERMO FISHER SCIENTIFIC INC. 307
TABLE 359 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 307
FIGURE 41 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 308
TABLE 360 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS 308
TABLE 361 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS 309
14.1.4 MERCK KGAA 311
TABLE 362 MERCK KGAA: COMPANY OVERVIEW 311
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022) 312
TABLE 363 MERCK KGAA: PRODUCT OFFERINGS 313
TABLE 364 MERCK KGAA: DEALS 313
TABLE 365 MERCK KGAA: OTHER DEVELOPMENTS 314
14.1.5 GETINGE AB 315
TABLE 366 GETINGE AB: COMPANY OVERVIEW 315
FIGURE 43 GETINGE AB: COMPANY SNAPSHOT (2022) 316
TABLE 367 GETINGE AB: PRODUCT OFFERINGS 316
TABLE 368 GETINGE AB: DEALS 317
TABLE 369 GETINGE AB: OTHER DEVELOPMENTS 317
14.1.6 EPPENDORF AG 318
TABLE 370 EPPENDORF AG: COMPANY OVERVIEW 318
FIGURE 44 EPPENDORF AG: COMPANY SNAPSHOT (2021) 319
TABLE 371 EPPENDORF AG: PRODUCT OFFERINGS 320
TABLE 372 EPPENDORF AG: PRODUCT LAUNCHES 321
TABLE 373 EPPENDORF AG: OTHER DEVELOPMENTS 322
14.1.7 ENTEGRIS, INC. 323
TABLE 374 ENTEGRIS, INC.: COMPANY OVERVIEW 323
FIGURE 45 ENTEGRIS, INC.: COMPANY SNAPSHOT (2022) 324
TABLE 375 ENTEGRIS, INC.: PRODUCT OFFERINGS 325
TABLE 376 ENTEGRIS, INC.: OTHER DEVELOPMENTS 325
14.1.8 AVANTOR 326
TABLE 377 AVANTOR: COMPANY OVERVIEW 326
FIGURE 46 AVANTOR: COMPANY SNAPSHOT (2022) 327
TABLE 378 AVANTOR: PRODUCT OFFERINGS 327
TABLE 379 AVANTOR: DEALS 328
TABLE 380 AVANTOR: OTHER DEVELOPMENTS 328
14.1.9 CORNING 329
TABLE 381 CORNING: COMPANY OVERVIEW 329
FIGURE 47 CORNING: COMPANY SNAPSHOT (2022) 330
TABLE 382 CORNING: PRODUCT OFFERINGS 330
14.1.10 CESCO BIOENGINEERING CO., LTD. 331
TABLE 383 CESCO BIOENGINEERING CO., LTD.: COMPANY OVERVIEW 331
TABLE 384 CESCO BIOENGINEERING CO., LTD.: PRODUCT OFFERINGS 331
14.1.11 KÜHNER AG 332
TABLE 385 KÜHNER AG: COMPANY OVERVIEW 332
TABLE 386 KÜHNER AG: PRODUCT OFFERINGS 332
TABLE 387 KÜHNER AG: DEALS 333
14.1.12 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING 334
TABLE 388 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY OVERVIEW 334
FIGURE 48 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY SNAPSHOT (2022) 335
TABLE 389 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: DEALS 336
TABLE 390 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: OTHER DEVELOPMENTS 337
14.1.13 PBS BIOTECH, INC. 338
TABLE 391 PBS BIOTECH, INC.: COMPANY OVERVIEW 338
TABLE 392 PBS BIOTECH, INC.: PRODUCT OFFERINGS 338
TABLE 393 PBS BIOTECH, INC.: OTHER DEVELOPMENTS 339
14.1.14 SATAKE MULTIMIX CORPORATION 340
TABLE 394 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW 340
TABLE 395 SATAKE MULTIMIX CORPORATION: PRODUCT OFFERINGS 340
14.1.15 G&G TECHNOLOGIES, INC. 341
TABLE 396 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW 341
TABLE 397 G&G TECHNOLOGIES, INC.: PRODUCT OFFERINGS 341
14.1.16 ABEC, INC. 342
TABLE 398 ABEC, INC.: COMPANY OVERVIEW 342
TABLE 399 ABEC, INC.: PRODUCT OFFERINGS 342
TABLE 400 ABEC, INC.: PRODUCT LAUNCHES 343
TABLE 401 ABEC, INC.: DEALS 343
TABLE 402 ABEC, INC.: OTHER DEVELOPMENTS 344
14.1.17 BBI-BIOTECH GMBH 345
TABLE 403 BBI-BIOTECH GMBH: COMPANY OVERVIEW 345
TABLE 404 BBI-BIOTECH GMBH: PRODUCT OFFERINGS 345
14.1.18 REPROCELL, INC. 346
TABLE 405 REPROCELL, INC.: COMPANY OVERVIEW 346
TABLE 406 REPROCELL, INC.: PRODUCT OFFERINGS 347
TABLE 407 REPROCELL, INC.: DEALS 347
14.1.19 CELLEXUS 348
TABLE 408 CELLEXUS: COMPANY OVERVIEW 348
TABLE 409 CELLEXUS: PRODUCT OFFERINGS 348
TABLE 410 CELLEXUS: DEALS 349
14.1.20 DISTEK, INC. 350
TABLE 411 DISTEK INC.: COMPANY OVERVIEW 350
TABLE 412 DISTEK, INC.: PRODUCT OFFERINGS 350
TABLE 413 DISTEK, INC.: PRODUCT LAUNCHES 351
14.2 OTHER PLAYERS 352
14.2.1 OMNIBRX BIOTECHNOLOGIES 352
14.2.2 NEW HORIZON BIOTECHNOLOGY INC. 353
14.2.3 GPC BIO 354
14.2.4 MEISSNER FILTRATION PRODUCTS INC. 355
14.2.5 CELL CULTURE COMPANY, LLC 356
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 358
15.1 DISCUSSION GUIDE 358
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 362
15.3 CUSTOMIZATION OPTIONS 364
15.4 RELATED REPORTS 365
15.5 AUTHOR DETAILS 366

★調査レポート[世界のシングルユースバイオリアクター(SUB)市場(~2028年):製品別(装置、メディアバッグ、ろ過アセンブリ)、種類別(攪拌槽、バブルカラム)、細胞タイプ別(哺乳類、バクテリア、酵母)、分子別(mAbs、ワクチン)、エンドユーザー別(製薬、バイオテクノロジー、CRO、CMO)、地域別] (コード:BT2863-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のシングルユースバイオリアクター(SUB)市場(~2028年):製品別(装置、メディアバッグ、ろ過アセンブリ)、種類別(攪拌槽、バブルカラム)、細胞タイプ別(哺乳類、バクテリア、酵母)、分子別(mAbs、ワクチン)、エンドユーザー別(製薬、バイオテクノロジー、CRO、CMO)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆